Delivery Order SPE2DB22D2006-SPE2DB25FW3TT
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 30 units, with a ceiling value of $3,320.50. This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion on August 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a typical transactional delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Terbinafine HCL 250 mg tablets (100-count) with a contract value of $2,205.41. This is a firm fixed-price delivery order with an ultimate completion date of July 25, 2025, and represents a non-competitive set-aside award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 30, with a ceiling value of $7,207.59. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for completion by September 17, 2025. AmerisourceBergen's place of performance is located in Conshohocken, Pennsylvania, reflecting the company's headquarters location and...
- The Defense Logistics Agency awarded a delivery order valued at $1,994.33 to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (90-count) on August 22, 2025, with a completion date of August 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a pharmaceutical supply delivery under the Defense Logistics Agency's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Terbinafine HCL 250 mg tablets (30-count packages) with a ceiling value of $4,107.11. This is a firm fixed-price delivery order with no set-aside designation, indicating the award resulted from open competitive procurement. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 100s, with a ceiling value of $11,707.25. The delivery order represents a firm fixed price, competitive award with no set-aside designation and an ultimate completion date of September 17, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for Terbinafine HCL 250 mg tablets (90-count supply) valued at $4,586.12. This firm fixed-price delivery order, with an ultimate completion date of September 10, 2025, represents a non-competitive set-aside award for pharmaceutical supply to support federal medical procurement needs. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Terbinafine HCL 250 mg tablets (100-count units) with a ceiling value of $1,128.60. This non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026. The product will be performed and delivered...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (30-count) on September 15, 2025, with a ceiling value of $42,385.52. This firm fixed-price delivery order, which is expected to be completed by September 16, 2025, represents a routine pharmaceutical procurement supporting federal medical supply needs. The contract was competitively awarded without set-aside provisions, demonstrating AmerisourceBergen's capability to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 30, with a ceiling value of $5,072.07. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award to the vendor based on standard federal procurement practices. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, and the order is scheduled...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW3TTDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 90 with a ceiling value of $2,139.57. This firm fixed-price delivery order, which is not set-aside, is set to be completed by August 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor in the federal medical procurement supply chain, particularly for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to supply a wide range of pharmaceutical products and medical supplies across multiple therapeutic domains. This specific delivery order represents a routine pharmaceutical supply transaction within AmerisourceBergen's ongoing role as a primary vendor supporting the Defense Health Agency and other federal healthcare systems through the DLA's pharmaceutical procurement operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 8/21/25 |